Microba Life Sciences Stock Forecast for 2023 - 2025 - 2030
Updated on 05/02/2024
Microba Life Sciences Stock Forecast and Price Target
The average price target for Microba Life Sciences's stock of $0.35 recently provided by leading analysts would represent a 84.21% upside from its last closing price if reached. This potential increase is based on a high estimate of $0.44 and a low estimate of $0.35. If you're interested in MAP stock, it's important to compare it to other companies in the industry.
84.21% Upside
Microba Life Sciences Fair Value Forecast for 2023 - 2025 - 2030
Microba Life Sciences's Price has seen impressive growth In the last two years, rising from $0.00 to $0.00 – a growth of 100.00%. In the next year, analysts believe that Fair Value will reach $0.00 – an increase of 100.00%. For the next six years, the forecast is for Fair Value to grow by 100.00%.
Microba Life Sciences Revenue Forecast for 2023 - 2025 - 2030
Microba Life Sciences's Revenue has seen impressive growth In the last year, rising from $4.69M to $5.42M – a growth of 15.57%. In the next year, 0 analysts estimate that Microba Life Sciences's Revenue will decrease by 13.47%, reaching $4.69M. According to professional forecasts, in 2030, Microba Life Sciences's Revenue will decrease by 8.75%, reaching $4.95M.
.jpg)
Microba Life Sciences EBITDA Forecast for 2023 - 2025 - 2030
In the last year, Microba Life Sciences's EBITDA has seen an increase, rising from $-15.56M to $-19.51M. This represents a growth of 25.39%. 0 analysts predict Microba Life Sciences's EBITDA will decrease by 20.25% in the next year, reaching $-15.56M. By 2030, professionals predict that Microba Life Sciences's EBITDA will decrease by 12.51%, to $-17.07M.
Microba Life Sciences EBIT Forecast for 2023 - 2025 - 2030
Microba Life Sciences's EBIT has seen growth In the last year, going from $-16.27M to $-20.23M – a gain of 24.34% For the following year, the 0 analysts predict that Microba Life Sciences's EBIT will drop by 19.57%, reaching $-16.27M. In 2030, the professionals' prediction is that MAP's EBIT will decrease by 12.15%, reaching $-17.77M.
Microba Life Sciences EPS Price Prediction Forecast for 2023 - 2025 - 2030
Microba Life Sciences's EPS has seen impressive growth In the last two years, rising from $-0.05 to $0.00 – a growth of 100.00%. In the next year, analysts believe that EPS will reach $0.00 – an increase of 100.00%. For the next six years, the forecast is for EPS to grow by 100.00%.
Site Navigation
.jpg)